MYSE
Myseum Inc.
There isn't enough reported data to score MYSE yet.
SNDK
Sandisk Corporation
SNDK's fundamentals are strong: revenue more than tripled and its operating margin went from −19% to 72%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
MYSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Unavailable |
MYSE's revenue is currently healthy, but its profitability is weak. There isn't enough data to rate its cash flow and balance sheet.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
MYSE PE Valuation
MYSE has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
MYSE Forward outlook
There aren't enough analyst estimates for MYSE to show an outlook.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for SNDK, with profitability improving.
MYSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2021 | -$2.65 | -$1.88 |
| Q2 2021 | -$1.69 | -$0.94 |
| Q1 2021 | -$1.34 | +$1.66 |
| Q4 2020 | -$0.73 | +$4.51 |
MYSE lost $1.25 per share over the past year, a smaller loss than the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over MYSE in the latest year-over-year earnings comparison.
MYSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $37 | -53% |
| Q1 2026 | $73 | -12% |
| Q4 2025 | $61 | -34% |
| Q3 2025 | $328 | +429% |
| Q2 2025 | $78 | -48% |
| Q1 2025 | $83 | -37% |
| Q4 2024 | $92 | -46% |
| Q3 2024 | $62 | -65% |
MYSE's revenue is growing: $37 last quarter, down 53% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5817057% | -4013431 points |
| Q1 2026 | -2308863% | -308326 points |
| Q4 2025 | -1872431% | -663521 points |
| Q3 2025 | -390427% | +1606644 points |
| Q2 2025 | -1803626% | -964485 points |
| Q1 2025 | -2000537% | -730752 points |
| Q4 2024 | -1208910% | -373353 points |
| Q3 2024 | -1997071% | -544413 points |
MYSE's operating margin was −5817057% last quarter, down 4013431 points from the same quarter a year ago, near the bottom of its range since 2022.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over MYSE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over MYSE on profitability, with a higher operating margin.
MYSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$1.3M | +$154.3K |
| Q1 2025 | -$1.4M | +$71.9K |
| Q4 2023 | -$1.4M | +$161.4K |
| Q3 2023 | -$2M | +$55.6K |
| Q3 2022 | -$2.1M | -$704.1K |
| Q1 2022 | -$2.3M | -$1.6M |
| Q3 2021 | -$1.3M | -$1M |
| Q1 2021 | -$650.2K | -$379.7K |
MYSE has burned cash in almost every quarter: −$4M over the past year, against −$6M the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
MYSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +16% | +699K shares |
| 1 year | +18% | +771K shares |
| 3 years | +142% | +2.9M shares |
| 5 years | +272% | +3.6M shares |
MYSE has 5M diluted shares, up 18% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over MYSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MYSE Net Leverage
MYSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
MYSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 0.6 | Oversold |
MYSE's weekly RSI is 34 (neutral) and its Stochastic is 1 (oversold).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
MYSE PE vs Technology Sector
MYSE has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
MYSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 29% below |
| 20 week MA | $2.11 | 50% below |
| 50 week MA | $2.05 | 48% below |
| 100 week MA | $2.31 | 54% below |
| 200 week MA | $2.59 | 59% below |
SNDK has stronger trend alignment. MYSE is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
MYSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $34.2 | $33.9 | -0.9% |
| 2022 | $33.9 | $3.15 | -91% |
| 2023 | $3.15 | $2.87 | -8.9% |
| 2024 | $2.87 | $1.84 | -36% |
| 2025 | $1.84 | $1.87 | +1.6% |
| 2026 YTD | $1.87 | $1.06 | -43% |
MYSE has finished lower in four of the last five years. It's down 43% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over MYSE on returns for 2026, with the stronger performance.